PMC:7534795 / 116371-116641
Annnotations
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T654 | 48-56 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T655 | 109-118 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T656 | 127-148 | Disease | denotes | respiratory disorders | http://purl.obolibrary.org/obo/MONDO_0005087 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T170 | 75-82 | http://purl.obolibrary.org/obo/CLO_0009985 | denotes | focuses |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T29626 | 39-44 | Chemical | denotes | PUFAs | http://purl.obolibrary.org/obo/CHEBI_26208 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T709 | 0-270 | Sentence | denotes | Thus, the rationale for the use of n-3 PUFAs in COVID-19 patients not only focuses on the attenuation of the infection-induced respiratory disorders but also on an overall improvement of patients' wellbeing and prevention of potential complications due to comorbidities. |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
3308 | 57-65 | Species | denotes | patients | Tax:9606 |
3309 | 187-195 | Species | denotes | patients | Tax:9606 |
3329 | 48-56 | Disease | denotes | COVID-19 | MESH:C000657245 |
3330 | 109-118 | Disease | denotes | infection | MESH:D007239 |
3331 | 127-148 | Disease | denotes | respiratory disorders | MESH:D012131 |